BriaCell Therapeutics Corporation   Report issue

For profit Phase 2 Phase 3
Founded: Berkeley CA United States (2004)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2017
NCT03066947
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

BriaCell Therapeutics Corporation